KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogenomics (NEO) Other Non Operating Income: 2009-2024

Historic Other Non Operating Income for Neogenomics (NEO) over the last 12 years, with Dec 2024 value amounting to -$379,000.

  • Neogenomics' Other Non Operating Income fell 205.68% to -$335,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$219,000, marking a year-over-year decrease of 224.43%. This contributed to the annual value of -$379,000 for FY2024, which is 158.85% down from last year.
  • According to the latest figures from FY2024, Neogenomics' Other Non Operating Income is -$379,000, which was down 158.85% from $644,000 recorded in FY2023.
  • In the past 5 years, Neogenomics' Other Non Operating Income registered a high of $7.9 million during FY2020, and its lowest value of -$499,000 during FY2021.
  • Over the past 3 years, Neogenomics' median Other Non Operating Income value was -$213,000 (recorded in 2022), while the average stood at $17,333.
  • Its Other Non Operating Income has fluctuated over the past 5 years, first soared by 402.35% in 2023, then plummeted by 158.85% in 2024.
  • Over the past 5 years, Neogenomics' Other Non Operating Income (Yearly) stood at $7.9 million in 2020, then crashed by 106.31% to -$499,000 in 2021, then skyrocketed by 57.31% to -$213,000 in 2022, then skyrocketed by 402.35% to $644,000 in 2023, then crashed by 158.85% to -$379,000 in 2024.